Accessibility Menu
Smith & Nephew Plc logo

Smith & Nephew Plc(NYSE) SNN

Market Cap$12.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)+462%
5 Year-14%
1 Year-20%
1 Month-11%
$29.01
-0.43%
-0.12Today
After hours$28.99-$0.02 (-0.05%)
Smith & Nephew Plc last closing stock price
MetricPriceDate
Last closeUSD 28.972026-08-28
Smith & Nephew Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.99%USD 29.262026-08-21
1 month-11.3%USD 32.662026-07-29
3 month-2.43%USD 29.692026-05-29
Year to date-10.36%USD 32.322025-12-31
1 year-20.35%USD 36.372025-08-28
3 year+15.37%USD 25.112023-08-29
5 year-14.23%USD 33.782021-08-27
Since inception+461.96%USD 5.161999-11-16

Smith & Nephew Plc Financials at a Glance

Market Cap

$12.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.24B

Net Income (TTM)

$1.13B

EPS (TTM)

$1.47

P/E Ratio

19.56

Dividend

$0.78

Beta (Volatility)

0.65 (Low)

Price

$29.01

Volume

1,488,335.735

Open

$28.89

Previous Close

$28.97

Daily Range

$28.75 - $29.03

52-Week Range

$28.56 - $38.79

Estimated Earnings Date

Feb 23, 2027

SNN News

Copy of senior man talking to doctor holding clipboard medical expenses healthcare hospital

3 Cheap Surgical Stocks to Buy Now Before They Bounce Back

James HalleyJul 9, 2020
GettyImages-1000656954

Can Medical Device Stocks Help Rebuild Your Portfolio?

David HaenMar 24, 2020
Getty Images Artificial Joint Total Knee Replacement

Why Shares of Smith & Nephew Fell 10.2% in October

John BromelsNov 12, 2019
GettyImages-511535378

Here's Why NuVasive Stock Is Soaring Today

Brian FeroldiFeb 11, 2019
MNKD inhalers

Why MannKind, Nutanix, and Smith & Nephew Jumped Today

Dan CaplingerOct 10, 2017
Dividends graphic

3 Best Dividend Stocks in the Medical Device Industry

Keith SpeightsJun 3, 2017
.Daily fool

Intel Staves Off the Dow's Drop

Dan CarrollJun 24, 2014
7650804342_5778937d0a_o

The 3 Best Tax Havens for Health Care Companies

Sean WilliamsJun 21, 2014
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Smith & Nephew plc is a global medical technology company that develops, manufactures, and sells medical devices and services. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, serving healthcare providers worldwide.

Products and Services
  • Knee and hip implants for joint replacement and revision procedures
  • Sports medicine products for minimally invasive surgeries and soft tissue repair
  • Advanced wound care solutions for chronic and acute wounds
Growth Outlook
  • Projected revenue growth driven by increasing demand for joint replacement surgeries
  • Expansion in emerging markets expected to enhance market share
  • Investment in R&D to innovate and improve product offerings
Financial Highlights
  • Q2 2026 revenue of $3.1 billion, reflecting strong market performance
  • Trailing twelve months (TTM) net income margin of 10.08%
  • Dividend yield of 2.62%, indicating a commitment to returning value to shareholders
Smith & Nephew plc has established itself as a leader in the medical devices industry, with a diverse product portfolio that addresses various healthcare needs. The company's focus on innovation and expansion into new markets positions it well for future growth. Recent financial performance highlights a robust revenue stream and a solid net income margin, reflecting operational efficiency. The commitment to returning value to shareholders through dividends further enhances its attractiveness to potential investors.
AI Generated • Aug 18, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

18,362

CEO

Deepak S Nath, PhD

Website

www.smith-nephew.com

Headquarters

Watford, HRT WD18 8YE, GB

SNN Financials

Key Financial Metrics (TTM)

Gross Margin

68.18%

Operating Margin

16.69%

Net Income Margin

10.08%

Return on Equity

12.25%

Return on Capital

9.22%

Return on Assets

5.81%

Earnings Yield

5.11%

Dividend Yield

2.70%

Payout Ratio

52.32%

Stock Overview

Market Cap

$12.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

418.51M

Volume

1.49M

Avg. Volume

1.50M

Financials (TTM)

Gross Profit

$8.51B

Operating Income

$1.57B

EBITDA

$2.82B

Operating Cash Flow

$2.48B

Capital Expenditure

-$832.00M

Free Cash Flow

$1.65B

Cash & ST Invst.

$754.00M

Total Debt

$3.79B

Smith & Nephew Plc Performance Analysis

Smith & Nephew Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 5,211,781,6180.0%
20232023-12-31USD 5,570,508,3216.9%
20242024-12-31USD 5,812,444,7834.3%
20252025-12-31USD 6,178,404,4716.3%
Smith & Nephew Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-315.5%
Q22025-06-30-0.7%
Q42025-12-318.2%
Q22026-06-27-3.3%
Smith & Nephew Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.51-57.2%
20232023-12-31USD 0.6018.5%
20242024-12-31USD 0.9455.6%
20252025-12-31USD 1.4452.5%
Smith & Nephew Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-8.0%
Q22025-06-3047.8%
Q42025-12-3111.8%
Q22026-06-27-7.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.10B

+9.6%

Gross Profit

$2.20B

+11.2%

Gross Margin

70.91%

N/A

Market Cap

$12.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$660.29K

N/A

Employees

18,362

N/A

Net Income

$303.00M

+41.6%

EBITDA

$748.00M

+24.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$754.00M

+32.7%

Total Debt

$3.79B

+3.6%

Accounts Receivable

$1.49B

+9.7%

Inventory

$2.11B

-15.2%

Long Term Debt

$3.21B

-1.9%

Short Term Debt

$573.00M

+50.8%

Return on Assets

5.81%

N/A

Return on Invested Capital

11.81%

N/A

Free Cash Flow

$260.00M

+293.9%

Operating Cash Flow

$450.00M

+89.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FMSFresenius Medical Care AG & Co. KGaA
$23.10-0.73%
TEMTempus AI, Inc.
$64.04-9.41%
COOThe Cooper Companies, Inc.
$71.17+0.30%
NBIXNeurocrine Biosciences, Inc.
$154.06-1.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$217.55-0.05%
PCGPG&E
$16.60-0.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.45-0.03%
IRENIren
$35.45-0.13%

Questions About SNN

What is the current price of Smith & Nephew Plc?

Smith & Nephew Plc is trading at $28.97 per share.

What is the 52-week range for Smith & Nephew Plc?

Over the past 52 weeks, Smith & Nephew Plc has traded between $28.56 and $38.79.

How much debt does Smith & Nephew Plc have?

As of the most recent reporting period, Smith & Nephew Plc reported total debt of $3.33B.

How much cash does Smith & Nephew Plc have on hand?

Smith & Nephew Plc reported $557.00M in cash and cash equivalents in its most recent financial results.

What is Smith & Nephew Plc’s dividend yield?

Smith & Nephew Plc currently has a dividend yield of 2.70%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services